Magnesium acts as a potential therapeutic agent in Visual Snow Syndrome by modulating neuronal excitability and reducing glutamatergic neurotransmission through NMDA receptor antagonism and calcium channel blockade. Its mechanism may help normalize cortical hyperexcitability and reduce abnormal neural signaling associated with the syndrome, potentially alleviating visual processing disturbances and neurological symptoms.